Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Nuvelo initiates phase II testing with alfimeprase in acute peripheral arterial occlusion

July 1, 2003

New factor Xa inhibitors and their use covered by Warner-Lambert patent

June 30, 2003

New antiplatelet agent of fungal origin identified by Aventis

June 23, 2003

Arixtra approved for extended use

June 23, 2003

Novel factor Xa inhibitors in early development at GSK

June 18, 2003

Phase III program under way for once-weekly idraparinux

June 17, 2003

Factor Xa inhibitors prepared and tested by Aventis researchers

June 17, 2003

Dosing under way in phase II catheter occlusion trial of alfimeprase

June 10, 2003

New factor Xa inhibitors, their preparation and use claimed by Kissei scientists

June 10, 2003

rFXIII enters third clinical study, gains orphan drug status

June 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...